COL4A3 mutations cause focal segmental glomerulosclerosis.

Area of Science:

• Nephrology
• Genetics
• Molecular Biology

Background:

• Focal segmental glomerulosclerosis (FSGS) is a kidney disease characterized by glomerular injury, often leading to proteinuria and renal failure.
• Identifying the genetic underpinnings of FSGS is crucial for understanding its pathogenesis and developing targeted therapies.
• Previous research has implicated various genes in hereditary kidney diseases, but the genetic landscape of FSGS remains incompletely understood.

Purpose of the Study:

• To identify the causal genes responsible for focal segmental glomerulosclerosis (FSGS) in a large Chinese cohort.
• To investigate the role of COL4A3 mutations in the etiology of FSGS, particularly in familial cases.
• To characterize the clinical and pathological features associated with COL4A3 mutations in FSGS patients.

Main Methods:

• Whole-exome sequencing and Sanger sequencing were employed to analyze genetic variations in FSGS families, sporadic FSGS patients, and healthy controls.
• Exclusion criteria were applied to rule out patients with systemic diseases or other known hereditary renal conditions.
• Electronic microscopy was used to examine glomerular structure in patients with identified mutations.

Main Results:

• Heterozygous COL4A3 mutations were identified in 12.5% of FSGS families and 2% of sporadic FSGS patients.
• All identified COL4A3 mutations affected highly conserved protein sequences and were absent in healthy controls.
• Segmental thinning of the glomerular basement membrane (GBM) was observed in an FSGS patient with heterozygous COL4A3 mutations.

Conclusions:

• A novel subgroup of FSGS patients caused by heterozygous COL4A3 mutations has been identified.
• COL4A3 mutations are a relatively frequent cause of inherited FSGS, particularly in families with a history of the disease.
• Screening for COL4A3 mutations is recommended for patients diagnosed with familial FSGS.